下肢潰瘍／壊疽患者に対する幹細胞研究

基本情報

NCT ID: NCT00221143
ステータス: 完了
試験のフェーズ: 第1/第2相
試験タイプ: 介入
目標被験者数: 15
治験依頼者名: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

概要

The purpose of this study is to determine if stem cell therapy with one's own cells (autologous cells) delivered intramuscularly to one's leg with ulcer and/or gangrene due to poor blood flow will be safe and if it will relieve leg pain, increase blood flow, and/or cure the leg wound.

対象疾患

Leg PainUlcerGangreneIschemiaPeripheral Vascular Diseases

介入

Autologous peripheral blood CD34 positive cell therapy(GENETIC)

依頼者（Sponsor）

Institute Of Biomedical Research And Innovation, Kobe, Hyogo, Japan(OTHER)

Kobe City General Hospital(OTHER)

Translational Research Center For Medical Innovation, Kobe, Hyogo, Japan(OTHER)

実施施設 (2)

Institute of Biomedical Research and Innovation

Kobe, Hyōgo, Japan

神戸市立医療センター中央市民病院

Kobe, Hyōgo, Japan